GenMark Diagnostics Schedules Fourth Quarter 2016 Financial Results Conference Call for February 28, 2017
February 09 2017 - 4:05PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it
plans to release its fourth quarter earnings results after market
close on Tuesday, February 28, 2017. Management will hold a
conference call to review the Company's financial performance
starting at 4:30 p.m. ET on the same day. The conference call will
be concurrently webcast. The link to the webcast will be available
on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under
the investor relations section and will be archived for future
reference. To listen to the conference call, please dial (877)
312-5847 (US/Canada) or (253) 237-1154 (International) and use the
conference ID number 51141106 approximately five minutes prior to
the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s sample-to-answer system, ePlex®.
For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170209005928/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident/Chief Executive
Officer760-448-4358
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Aug 2024 to Sep 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Sep 2023 to Sep 2024